Angiodynamics Inc Issues Q3 2013 Guidance Below Analysts' Estimates


Thursday, 7 Mar 2013 04:30pm EST 

Angiodynamics Inc announced that it expects to report net sales for the third quarter of 2013 to be approximately $82 million and expects to report adjusted net income for the third quarter in the range of $0.04 per share to $0.06 per share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues $89 million and EPS of $0.09 for the third quarter of 2013. 

Company Quote

19.245
-0.475 -2.41%
30 Jan 2015